Lippi G, Lo Cascio C, Ruzzenente O, Brentegani C, Guidi G
Laboratorio di Analisi Chimico-Cliniche e Microbiologiche, Università di Verona, Centro Ospedaliero Clinicizzato, Italy.
Clin Chim Acta. 1996 Dec 30;256(2):125-34. doi: 10.1016/s0009-8981(96)06413-3.
Despite the increasing interest in the measurements of lipoprotein(a) (Lp(a) in serum or plasma, at present there is no effective standardization for Lp(a) assays; the main problems to solve are represented either by the lack of a suitable primary standard or by the absence of a reliable and widely available reference method. A first step is hence the uniformity of calibration of different immunoassays. We calibrated three commercial immunoassays for Lp(a) (enzyme linked immunosorbent assay (ELISA), latex-enhanced immunonephelometric assay (LINA), and immunonephelometric assay (INA) with either proprietary standards or purified Lp(a) material obtained with a rapid and simple procedure. Final results of purified Lp(a) calibration were reported in terms of protein Lp(a) mass whereas we were able to quantify the exact protein concentration of our purified lipoprotein. The uniformity of the calibration of the different assays led to a significant improvement of regression slopes (from 1.88 to 0.90 ELISA vs. LINA, from 1.45 to 0.95 ELISA vs. INA and from 1.27 to 0.96 INA vs. LINA) and correlation coefficients (from 0.990 to 0.994 ELISA vs. LINA, from 0.987 to 0.990 ELISA vs. INA and from 0.985 to 0.987 INA vs. LINA). Furthermore, the significant differences among Lp(a) values obtained after calibration with proprietary standards were minimized, becoming non-significant in two out of three cases. In conclusion, we demonstrated that a better agreement of Lp(a) values obtained with different commercial assays could be simply reached by uniformity of calibration and by employing standards with values accurately measured.
尽管人们对血清或血浆中脂蛋白(a)[Lp(a)]的测量越来越感兴趣,但目前Lp(a)检测尚无有效的标准化方法;要解决的主要问题要么是缺乏合适的一级标准品,要么是缺乏可靠且广泛可用的参考方法。因此,第一步是实现不同免疫测定法校准的一致性。我们使用专有标准品或通过快速简单程序获得的纯化Lp(a)材料,对三种用于Lp(a)的商业免疫测定法(酶联免疫吸附测定法[ELISA]、乳胶增强免疫比浊法[LINA]和免疫比浊法[INA])进行了校准。纯化Lp(a)校准的最终结果以蛋白质Lp(a)质量表示,而我们能够对纯化脂蛋白的精确蛋白质浓度进行定量。不同测定法校准的一致性使回归斜率(ELISA与LINA相比,从1.88提高到0.90;ELISA与INA相比,从1.45提高到0.95;INA与LINA相比,从1.27提高到0.96)和相关系数(ELISA与LINA相比,从0.990提高到0.994;ELISA与INA相比,从0.987提高到0.990;INA与LINA相比,从0.985提高到0.987)有了显著改善。此外,用专有标准品校准后获得的Lp(a)值之间的显著差异被最小化,在三种情况中有两种变得不显著。总之,我们证明,通过校准的一致性和使用准确测量值的标准品,可以简单地使不同商业测定法获得的Lp(a)值达成更好的一致性。